Pantoprazol Actavis (Pantoprazole Sodium)

Pantoprazole Sodium, the active ingredient in Pantoprazol Actavis, is a proton pump inhibitor presented as a unknown strength/unknown form for oral use. It reduces gastric acid secretion and is used to treat conditions such as gastro‑oesophageal reflux disease and Zollinger‑Ellison syndrome in adults.

GNH USA supplies Pantoprazol Actavis as a licensed, GDP‑compliant international pharmaceutical supplier serving hospitals, pharmacies and clinics worldwide.

Pantoprazol Actavis is a proton pump inhibitor that acts on the gastric acid secretion pathway, providing therapeutic benefit in several acid‑related disorders. - Gastro‑oesophageal reflux disease (GERD): Improves symptom relief and promotes healing of the oesophageal lining. - Erosive esophagitis: Facilitates healing of erosive lesions in the esophagus. - Zollinger‑Ellison syndrome: Controls excessive gastric acid production associated with this rare condition.

Pantoprazol Actavis may cause a range of adverse reactions, most of which are mild and reversible.

Common Side Effects: - Headache - Diarrhea - Nausea - Abdominal pain - Flatulence - Constipation

Serious or Rare Side Effects: - Severe allergic reaction (anaphylaxis) - Clostridioides difficile‑associated colitis - Low magnesium levels (hypomagnesemia) - Acute interstitial nephritis - Fracture risk with long‑term use - Liver enzyme abnormalities

When prescribing Pantoprazol Actavis, clinicians should consider several safety aspects. - Assess risk of renal or hepatic impairment: dose adjustment may be ​​ ​   - Monitor for potential drug interactions with clopidog and warfar  - Advise patients to report any persistent gastro‑  - Use caution in preg  d  t  t \